RPG Life Sciences Ltd

📈 Clarus Capital Acquires Additional Stake in RPG Life Sciences, Crosses 5% Threshold

• Clarus Capital I (SEBI registered Category III AIF) and PAC ClearEdge LLC acquired shares in RPG Life Sciences Limited

• Acquisition date: April 17, 2026 via open market purchases

• Pre-acquisition holding: 749,734 shares (4.53% of total capital)

• Additional shares acquired: 145,113 shares (0.88% of total capital)

• Post-acquisition holding: 894,847 shares (5.41% of total capital)